Definitive Healthcare (NASDAQ:DH) Issues Q2 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its second quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.08-$0.09 for the period, compared to the consensus EPS estimate of $0.09. The company issued revenue guidance of $62.0-$63.5 million, compared to the consensus revenue estimate of $65.19 million. Definitive Healthcare also updated its FY24 guidance to $0.36-$0.38 EPS.

Analyst Ratings Changes

Several research firms have recently weighed in on DH. Needham & Company LLC cut Definitive Healthcare from a buy rating to a hold rating in a report on Wednesday, January 17th. Canaccord Genuity Group lifted their price objective on Definitive Healthcare from $9.00 to $10.00 and gave the company a hold rating in a report on Thursday, February 29th. Barclays lifted their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a report on Friday, March 1st. Finally, Stifel Nicolaus cut their target price on Definitive Healthcare from $12.00 to $11.00 and set a buy rating on the stock in a research note on Wednesday, January 17th. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Definitive Healthcare presently has a consensus rating of Hold and a consensus price target of $11.31.

Definitive Healthcare Stock Down 1.2 %

NASDAQ DH traded down $0.09 during trading on Tuesday, hitting $7.25. The stock had a trading volume of 480,437 shares, compared to its average volume of 560,899. The company has a market capitalization of $853.98 million, a PE ratio of -4.07, a P/E/G ratio of 6.12 and a beta of 1.41. The company’s 50-day moving average price is $7.82 and its two-hundred day moving average price is $8.31. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare has a 12 month low of $5.53 and a 12 month high of $12.45.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. As a group, sell-side analysts forecast that Definitive Healthcare will post 0.11 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.